KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Net Income towards Common Stockholders (2016 - 2025)

Boston Scientific's Net Income towards Common Stockholders history spans 17 years, with the latest figure at $672.0 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 18.94% year-over-year to $672.0 million; the TTM value through Dec 2025 reached $2.9 billion, up 56.4%, while the annual FY2025 figure was $2.9 billion, 56.4% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $672.0 million at Boston Scientific, down from $755.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $797.0 million in Q2 2025 and bottomed at $80.0 million in Q4 2021.
  • The 5-year median for Net Income towards Common Stockholders is $366.0 million (2021), against an average of $397.4 million.
  • The largest annual shift saw Net Income towards Common Stockholders skyrocketed 2872.73% in 2021 before it tumbled 70.34% in 2022.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $80.0 million in 2021, then soared by 57.5% to $126.0 million in 2022, then skyrocketed by 300.79% to $505.0 million in 2023, then rose by 11.88% to $565.0 million in 2024, then increased by 18.94% to $672.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Net Income towards Common Stockholders are $672.0 million (Q4 2025), $755.0 million (Q3 2025), and $797.0 million (Q2 2025).